 double blind placebo trial low dose clotrimazole rheumatoid arthritis Seventy-three patients rheumatoid arthritis double blind study clotrimazole mg/kg/day days week weeks placebo Patients clotrimazole significant improvements baseline measurements grip strength joint count patient assessment pain significant improvement patients placebo adverse experiences gastrointestinal complaints patients clotrimazole patients therapy